Oncolytic Virus Therapy That Destroys Cancer In Solid Tumors Given To First Patient In New Trial.

The first patient in a running phase 1 clinical trial has been dosed with a new experimental therapy that uses an engineered virus to kill off cancer cells selectively, Imugene Limited and City of Hope have announced.

Oncolytic viruses are specifically designed to replicate inside cancer cells, then destroy them without harming the normal surrounding cells.

Earlier work has shown that oncolytic viruses such as CF33-hNIS are stable and are suitable therapeutic tools that support the translation of this therapy into a clinical setting.

Read more about this exciting breakthrough trial: https://www.iflscience.com/health-and-medicine/oncolytic-virus-therapy-that-destroys-cancer-in-solid-tumors-given-to-first-patient-in-new-trial/.